Bruce W. Bode

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.8K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes

Melanie J. Davies, Richard M. Bergenstal, Bruce W. Bode et al. · JAMA · 2015 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial

Alan J. Garber, Robert R. Henry, Robert E. Ratner et al. · The Lancet · 2008 · 1.1K citations

Medicine, Endocrinology, Pharmacotherapy +13

Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States

Bruce W. Bode, Valerie Garrett, Jordan Messler et al. · Journal of Diabetes Science and Technology · 2020 · 786 citations · Full text

Medicine, Internal Medicine, Diabetology +14

The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System

Timothy S. Bailey, Bruce W. Bode, Mark P. Christiansen et al. · Diabetes Technology & Therapeutics · 2015 · 680 citations · Full text

Medicine, Endocrinology, Internal Medicine +17